Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures
暂无分享,去创建一个
N. Schultz | S. Larson | T. Graeber | I. Mellinghoff | H. Christofk | J. ten Hoeve | A. Multani | E. Port | Hong Wu | N. Graham | Ashley A. Cass | D. Braas | R. Qiao | Nicolaos J Palaskas | M. Müschen | James Go | N. Balanis | Aspram Minasyan | C. Ng | A. Lomova | Michael Friedman | S. Chan | Sophie R. Zhao | Adrian Delgado | L. Beck | C. Hurtz | N. Palaskas
[1] K. Chin,et al. In situ analyses of genome instability in breast cancer , 2004, Nature Genetics.
[2] T. Graeber,et al. Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death , 2012, Molecular systems biology.
[3] Hanna Y. Irie,et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment , 2009, Nature.
[4] D. Cleveland,et al. Losing balance: the origin and impact of aneuploidy in cancer , 2012, EMBO reports.
[5] D. Pe’er,et al. Integration of Genomic Data Enables Selective Discovery of Breast Cancer Drivers , 2014, Cell.
[6] Trey Ideker,et al. Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..
[7] Han Xie,et al. Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells. , 2014, Cell metabolism.
[8] Benjamin J. Raphael,et al. Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin , 2014, Cell.
[9] Jason M. Sheltzer,et al. A transcriptional and metabolic signature of primary aneuploidy is present in chromosomally unstable cancer cells and informs clinical prognosis. , 2013, Cancer research.
[10] S. Elledge,et al. Cumulative Haploinsufficiency and Triplosensitivity Drive Aneuploidy Patterns and Shape the Cancer Genome , 2013, Cell.
[11] Chris Sander,et al. Copy number alteration burden predicts prostate cancer relapse , 2014, Proceedings of the National Academy of Sciences.
[12] Barry Halliwell,et al. Oxidative stress in cell culture: an under‐appreciated problem? , 2003, FEBS letters.
[13] V. Ferrans,et al. Ras Proteins Induce Senescence by Altering the Intracellular Levels of Reactive Oxygen Species* , 1999, The Journal of Biological Chemistry.
[14] G. Getz,et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.
[15] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[16] the original work is properly cited. , 2022 .
[17] Gerald C. Chu,et al. Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.
[18] Gerald C. Chu,et al. Telomerase Reactivation following Telomere Dysfunction Yields Murine Prostate Tumors with Bone Metastases , 2012, Cell.
[19] A. Regev,et al. The Histone Deacetylase SIRT6 Is a Tumor Suppressor that Controls Cancer Metabolism , 2012, Cell.
[20] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[21] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[22] Gregory Stephanopoulos,et al. Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells. , 2009, Journal of biotechnology.
[23] Derek Y. Chiang,et al. The landscape of somatic copy-number alteration across human cancers , 2010, Nature.
[24] J. Ochocki,et al. Fructose-1, 6-bisphosphatase opposes renal carcinoma progression , 2014, Nature.
[25] David Beach,et al. Glycolytic enzymes can modulate cellular life span. , 2005, Cancer research.
[26] Gregory Stephanopoulos,et al. Amplification of phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis , 2012, BMC Proceedings.
[27] Li-Ju Chang,et al. Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth. , 2014, Cell reports.
[28] K. Kinzler,et al. Genetic instability and darwinian selection in tumours. , 1999, Trends in cell biology.
[29] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[30] Darawalee Wangsa,et al. Chromosome mis-segregation and cytokinesis failure in trisomic human cells , 2015, eLife.
[31] T. Shlomi,et al. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence , 2013, Nature.
[32] M. Yi,et al. Aneuploidy, oncogene amplification and epithelial to mesenchymal transition define spontaneous transformation of murine epithelial cells. , 2013, Carcinogenesis.
[33] Steven J. M. Jones,et al. Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.
[34] C. Larsson,et al. Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping , 2000, Genes, chromosomes & cancer.
[35] H. Saya,et al. Mitogenic signalling and the p16INK4a–Rb pathway cooperate to enforce irreversible cellular senescence , 2006, Nature Cell Biology.
[36] M. Meyerson,et al. Recurrent Hemizygous Deletions in Cancers May Optimize Proliferative Potential , 2012, Science.
[37] Hong Sun,et al. Analysis of growth properties and cell cycle regulation using mouse embryonic fibroblast cells. , 2007, Methods in molecular biology.
[38] Cristina Montagna,et al. Aneuploidy acts both oncogenically and as a tumor suppressor. , 2007, Cancer cell.
[39] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[40] R. DePinho,et al. Cellular Senescence Minireview Mitotic Clock or Culture Shock? , 2000, Cell.
[41] L. Chin,et al. Passenger Deletions Generate Therapeutic Vulnerabilities in Cancer , 2012, Nature.
[42] Steven J. M. Jones,et al. Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.
[43] K. Chin,et al. Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations , 2014, Cell cycle.
[44] J. Clement,et al. Abstract 5164: Selectively enriched CD90/Thy-1-positive cells from peripheral blood allow discrimination of patients and further analysis on a single cell level , 2011 .
[45] S. Apte,et al. Cellular Respiration and Carcinogenesis , 2009 .
[46] Angelika Amon,et al. Aneuploidy Affects Proliferation and Spontaneous Immortalization in Mammalian Cells , 2008, Science.
[47] L. Lim,et al. A microRNA component of the p53 tumour suppressor network , 2007, Nature.
[48] S. Nelson,et al. Melanoma whole exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance , 2012, Nature Communications.
[49] S. Melov,et al. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts , 2003, Nature Cell Biology.
[50] S. Lowe,et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. , 2007, Cancer cell.
[51] J. Postlethwait,et al. Comparative Oncogenomic Analysis of Copy Number Alterations in Human and Zebrafish Tumors Enables Cancer Driver Discovery , 2013, PLoS genetics.
[52] K. Kinzler,et al. Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells , 2009, Science.
[53] H. Kondoh. The Role of Glycolysis in Cellular Immortalization , 2009 .
[54] G. Wahl,et al. MDM2, MDMX and p53 in oncogenesis and cancer therapy , 2013, Nature Reviews Cancer.
[55] Orly Alter,et al. Tensor GSVD of Patient- and Platform-Matched Tumor and Normal DNA Copy-Number Profiles Uncovers Chromosome Arm-Wide Patterns of Tumor-Exclusive Platform-Consistent Alterations Encoding for Cell Transformation and Predicting Ovarian Cancer Survival , 2015, PloS one.
[56] V. Mootha,et al. Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation , 2012, Science.
[57] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[58] Karen Blyth,et al. Serine starvation induces stress and p53 dependent metabolic remodeling in cancer cells , 2012, Nature.
[59] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[60] L. Chin,et al. Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers , 2007, Nature.
[61] A. Sablina,et al. Loss of Chromosome 8p Governs Tumor Progression and Drug Response by Altering Lipid Metabolism. , 2016, Cancer cell.
[62] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[63] T. Mak,et al. Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.
[64] Peter Bouwman,et al. BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance. , 2011, Cancer cell.
[65] Chunxu Qu,et al. Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain. , 2011, Cancer cell.
[66] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[67] W. Wheaton,et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity , 2010, Proceedings of the National Academy of Sciences.
[68] M. Nikiforov,et al. Oncogene-Induced Senescence , 2017, Methods in Molecular Biology.
[69] J. Rabinowitz,et al. Kinetic flux profiling for quantitation of cellular metabolic fluxes , 2008, Nature Protocols.
[70] Chris Sander,et al. Emerging landscape of oncogenic signatures across human cancers , 2013, Nature Genetics.
[71] M. Schwaiger,et al. Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[72] Robert Tibshirani,et al. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer , 2006, Genes, chromosomes & cancer.
[73] C. Swanton,et al. Cancer chromosomal instability: therapeutic and diagnostic challenges , 2012, EMBO reports.
[74] G. Stamp,et al. Binding of Ras to Phosphoinositide 3-Kinase p110α Is Required for Ras- Driven Tumorigenesis in Mice , 2007, Cell.
[75] S. Horvath,et al. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4. , 2016, Cell reports.
[76] P. Kleihues,et al. Genetic pathways to primary and secondary glioblastoma. , 2007, The American journal of pathology.
[77] C. Dang. MYC, metabolism, cell growth, and tumorigenesis. , 2013, Cold Spring Harbor perspectives in medicine.
[78] 이연수. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer , 2011 .
[79] 高橋弥生,et al. 大腸癌におけるcopy number alterationを用いた層別化解析 , 2017 .
[80] J. Gray,et al. Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. , 2013, Cancer cell.
[81] Abhishek K. Jha,et al. Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. , 2013, Cancer cell.
[82] Mingming Jia,et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..
[83] Susumu Goto,et al. Data, information, knowledge and principle: back to metabolism in KEGG , 2013, Nucleic Acids Res..
[84] L. Liau,et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.
[85] M. Cascante,et al. Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism? , 1998, Medical hypotheses.
[86] M. Cookson,et al. Hexokinase activity is required for recruitment of parkin to depolarized mitochondria. , 2014, Human molecular genetics.
[87] Michael L. Gatza,et al. An integrated genomics approach identifies drivers of proliferation in luminal subtype human breast cancer , 2014, Nature Genetics.
[88] C. Greider,et al. Genomic instability in both wild-type and telomerase null MEFs , 2004, Chromosoma.
[89] D. Housman,et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.
[90] J. D. Weber,et al. The ARF/p53 pathway. , 2000, Current opinion in genetics & development.
[91] William R Sellers,et al. Linking somatic genetic alterations in cancer to therapeutics. , 2009, Current opinion in cell biology.
[92] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..
[93] P. Fisher. Cancer Genomics and Proteomics , 2007, Methods in Molecularbiology™.
[94] N. Dhomen,et al. Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53 , 2014, Nature.
[95] Hong Sun,et al. Analysis of transformation and tumorigenicity using mouse embryonic fibroblast cells. , 2007, Methods in molecular biology.
[96] T. Jacks,et al. Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome , 2004, Cell.
[97] Chris Sander,et al. 18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers. , 2011, Cancer research.
[98] Shaying Zhao,et al. Cancer driver-passenger distinction via sporadic human and dog cancer comparison: a proof of principle study with colorectal cancer , 2013, Oncogene.
[99] P. Robson,et al. Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis , 2012, Cell.
[100] H. Green,et al. QUANTITATIVE STUDIES OF THE GROWTH OF MOUSE EMBRYO CELLS IN CULTURE AND THEIR DEVELOPMENT INTO ESTABLISHED LINES , 1963, The Journal of cell biology.
[101] Steven J. M. Jones,et al. Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.
[102] Yuji Hiramatsu,et al. The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer. , 2011, Gynecologic oncology.
[103] A. Ooi,et al. Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA , 2015, Clinical Cancer Research.
[104] D. Karolchik,et al. The UCSC Genome Browser database: 2016 update , 2015, bioRxiv.
[105] G. Semenza,et al. Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1 , 2007, Molecular and Cellular Biology.
[106] C. Sander,et al. Identifying Actionable Targets through Integrative Analyses of GEM Model and Human Prostate Cancer Genomic Profiling , 2014, Molecular Cancer Therapeutics.
[107] Jason W. Locasale,et al. Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses , 2011, Science.
[108] Jason I. Herschkowitz,et al. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells , 2011, Proceedings of the National Academy of Sciences.
[109] Steven J. M. Jones,et al. Integrated genomic characterization of endometrial carcinoma , 2013, Nature.
[110] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[111] Wen-Lin Kuo,et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.